Medindia

X

MusclePharm(R) Wins New Brand of Year at Mr. Olympia Show

Wednesday, October 14, 2009 General News J E 4
Advertisement

DENVER, Oct. 14 -- Being chosen as Rookie of the Year is an incredible achievement, no matter what your sport. In the supplement industry, this recognition is no less significant. MusclePharm(R) is proud to have the distinction of being chosen Bodybuilding.com's New Brand of the Year for 2009.

This prestigious award is high praise coming from the likes of Bodybuilding.com. The Bodybuilding.com Supplement Awards are the gold standard for the fitness and supplement industry. The exciting thing about these awards is that they are based on sales (which is like a vote from a customer in itself) and on input from the general public, making the results completely objective and unbiased, and all the more valuable to potential new customers.

"It is truly an honor to be awarded the distinction of Bodybuilding.com's New Brand of the Year," states MusclePharm's CEO, Brad Pyatt. "There are a tremendous number of new brands out there. We're proud to be recognized for our efforts to bring the best possible products to athletes everywhere.

"I would like to thank all of our loyal MusclePharm(R) supporters who have been with us since the beginning and our valued customers - without whom none of this would be possible."

About MusclePharm(R):

MusclePharm(R) is a company founded by athletes, for athletes. We take pride in putting 100% of our energy and effort into making the most effective products money can buy. We use only top-quality ingredients in efficacious dosages to make up our comprehensive, complete formulations. Each of our products has been tested for purity and for effect. Check out MusclePharm(R) products and see for yourself why Bodybuilding.com's customers chose us as New Brand of the Year!

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.

SOURCE MusclePharm

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ZyStor Therapeutics, Inc. Cleared to Begin Clinica...
S
Slumps in Pharmaceutical Profitability Tied to Ins...